Suppr超能文献

利用随机肽库对血小板糖蛋白IIb/IIIa上自身抗原表位的鉴定

Characterization of autoantigenic epitopes on platelet glycoprotein IIb/IIIa using random peptide libraries.

作者信息

Bowditch R D, Tani P, Fong K C, McMillan R

机构信息

The Scripps Research Institute, La Jolla, CA 92037, USA.

出版信息

Blood. 1996 Dec 15;88(12):4579-84.

PMID:8977249
Abstract

Most patients with chronic immune thrombocytopenic purpura (ITP) have autoantibodies directed against the glycoprotein (GP) IIb/IIIa complex. We have used a filamentous phage library that displays random linear hexapeptides to identify peptide sequences recognized by these autoantibodies. Plasma antibody eluates from two patients were used to select for phage displaying autoantibody-reactive peptides. From patient ITP-1 (known to have two distinct autoantibodies), we identified anti-GPIIb/IIIa antibody-specific phage encoding the peptide sequences Arg-Glu-Lys-Ala-Lys-Trp (REKAKW) and Pro-Val-Val-Trp-Lys-Asn (PVVWKN). Patient ITP-2 bound phage encoding the hexapeptide sequence Arg-Glu-Leu-Leu-Lys-Met. Each phage showed saturable dose-dependent binding to immobilized autoantibody, and binding could be blocked with purified GPIIb/IIIa. Patient ITP-1 autoantibody recognition of phage encoding REKAKW could be blocked with a synthetic peptide derived from the GPIIIa cytoplasmic tail; however, the PVVWKN was not. Using sequential overlapping peptides from the GPIIIa cytoplasmic region, an epitope for ITP-1 was localized to the sequence Arg-Ala-Arg-Ala-Lys-Trp (GPIIIa 734-739). Inhibition studies using synthetic peptides showed that phage REKAKW and PVVWKN were recognized by distinct autoantibodies from patient ITP-1. To determine whether individual patients with ITP possessed autoantibodies that recognize similar antigenic determinants on GPIIb/IIIa, the three phage were tested for binding to five other ITP patient autoantibodies. The phage encoding the peptide PVVWKN was found to bind ITP-1 and one other patient autoantibody. This result suggests that ITP patients recognize a limited number of shared epitopes.

摘要

大多数慢性免疫性血小板减少性紫癜(ITP)患者具有针对糖蛋白(GP)IIb/IIIa复合物的自身抗体。我们使用了一个展示随机线性六肽的丝状噬菌体文库来鉴定这些自身抗体识别的肽序列。来自两名患者的血浆抗体洗脱物用于筛选展示自身抗体反应性肽的噬菌体。从患者ITP-1(已知有两种不同的自身抗体)中,我们鉴定出编码肽序列Arg-Glu-Lys-Ala-Lys-Trp(REKAKW)和Pro-Val-Val-Trp-Lys-Asn(PVVWKN)的抗GPIIb/IIIa抗体特异性噬菌体。患者ITP-2结合了编码六肽序列Arg-Glu-Leu-Leu-Lys-Met的噬菌体。每个噬菌体与固定化自身抗体的结合呈现饱和剂量依赖性,并且结合可以被纯化的GPIIb/IIIa阻断。患者ITP-1对编码REKAKW的噬菌体的自身抗体识别可以被源自GPIIIa胞质尾的合成肽阻断;然而,PVVWKN则不能。使用来自GPIIIa胞质区域的连续重叠肽,ITP-1的一个表位被定位到序列Arg-Ala-Arg-Ala-Lys-Trp(GPIIIa 734-739)。使用合成肽的抑制研究表明,噬菌体REKAKW和PVVWKN被患者ITP-1的不同自身抗体识别。为了确定ITP个体患者是否拥有识别GPIIb/IIIa上相似抗原决定簇的自身抗体,测试了这三种噬菌体与其他五名ITP患者自身抗体的结合情况。发现编码肽PVVWKN的噬菌体与ITP-1和另一名患者的自身抗体结合。这一结果表明ITP患者识别有限数量的共享表位。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验